A pharma warehouse is never just holding stock — it is protecting three things at the same time. It is protecting the product, which has to stay inside its licensed storage conditions from goods receipt to dispatch. It is protecting the batch, which has to remain segregated by status, rotatable by expiry, and traceable across every movement. And it is protecting the audit trail, which has to satisfy an inspector who arrives without notice and expects a complete record inside a 24–48 hour retrieval window. Miss any one and the FDA Form 483 that follows lists the same warehouse — for three different reasons.
iFactory / GMP-compliant pharma warehouse management
Protect Product, Batch, and Audit Trail — Without Paper Chaos
A pharma WMS built around 21 CFR Part 211, Part 11, and USP <1079> — where every movement, temperature reading, quarantine decision, and expiry check is captured live and inspection-ready from the moment it happens.
P
Product
Storage conditions, potency, containment
B
Batch
Lot control, quarantine status, FEFO
A
Audit trail
21 CFR Part 11, 24–48h retrieval
21 CFR 211
+ Part 11 electronic records
27%
of GDP findings are storage/temperature
24–48h
FDA record retrieval window
The Problem on the Floor
A pharma warehouse looks like any other warehouse at first — pallets, racks, forklifts, dock doors. The difference is what the record has to prove. Every pallet has a batch ID, every batch has a status (released, quarantine, rejected), every location has a licensed condition range, every movement needs a signature, every temperature reading has to be tamper-evident. For-cause FDA inspections doubled from 2022 to 2024, and temperature and storage conditions account for more than 27% of major and critical GDP findings. When the record lives in three paper logs and a chart recorder, the warehouse cannot answer an inspector inside the 24-48 hour retrieval window.
What Escapes Into the System of Record Today
Pharma warehouses know what data they are supposed to hold. The failure mode is not intent — it is that the data lives in places a regulator cannot inspect and a QA head cannot query without a week of manual reconstruction.
Paper batch log
Goods-receipt batch log filled by hand at the dock. Quarantine release note signed on paper and filed. When the auditor asks for movement history on Batch 24-B-1149, three people search three cabinets.
Spreadsheet
Master expiry list maintained on a shared Excel workbook, updated at month-end. Location assignments live on a separate sheet. Neither reconciles automatically against the ERP batch record.
Chart recorder / data logger
Chart recorder in the 2–8°C cold room prints a paper roll. Nobody reads it unless there is a suspected excursion. Data logger downloads happen quarterly at qualification review — not continuously.
Nowhere at all
Handling exceptions — a pallet moved without a signed movement record, a batch released before QA sign-off — often have no digital record at all. They surface at the next mock audit or at the next inspection Form 483.
What the WMS Actually Does
A GMP-compliant pharma WMS is not a taller version of a distribution WMS. It is a record layer purpose-built for lot control, quarantine status, storage-condition enforcement, and 21 CFR Part 11 electronic-signature discipline — with every action captured live, not reconciled monthly.
Lot Control
Every pallet, tote, and unit carries its batch, sub-batch, and expiry. FEFO enforced at pick. Quarantine status blocks release before any human decision.
Discipline: batch-level
Storage Enforcement
Each location mapped to its licensed storage-condition range (CRT, cool, 2–8°C, frozen, ULT). Wrong-zone put-away refused at the scan.
Discipline: zone-locked
Environmental Data
Continuous temperature, humidity, and differential-pressure readings against location baselines, with alarm acknowledgment captured with e-signature.
Discipline: continuous
Audit Trail
Every movement, every status change, every override captured with user, timestamp, reason code — the trail an inspector actually reads.
Discipline: tamper-evident
What Gets Written to the System of Record
What separates a compliant WMS from a warehouse app is what lands in the system of record. Every action produces the specific object a regulator, a QA head, or a customer complaint investigator will look for.
Batch Master Record
GMP WMS / ERP
Every batch’s status, location, quantity, expiry, quarantine reason, and release history — the record the auditor asks for by batch ID first.
Movement Log
21 CFR Part 11
Every put-away, transfer, pick, and cycle count with user, timestamp, reason code, and electronic signature. No orphan movements, no ghost inventory.
Environmental Record
Monitoring System
Continuous temperature and humidity per storage zone, with excursion events, alarm acknowledgment, and CAPA link when the excursion triggered a batch hold.
Inspection Export
Compliance Layer
One-click export of batch history, movement log, and environmental record for any date range — the artefact the FDA 24–48h retrieval window expects.
Try the FDA 24-hour test on your current warehouse: pick one batch, ask for its full movement, temperature, and quarantine history for the last 90 days. If the answer takes more than a day to assemble, the audit clock is not on your side. Book a warehouse audit — we’ll benchmark your retrieval time against the regulator’s.
12-Week Pilot Shape on One Warehouse
One warehouse, one product family, twelve weeks. The pilot is not scoped to prove that a WMS works. It is scoped to prove that the pharma-specific compliance layer — batch control, storage enforcement, environmental capture, audit trail — satisfies a mock FDA inspection on your product, in your facility, with your team.
Weeks 1–2
Discovery & Mapping
Walk the current process. Map every batch state, every location zone, every SOP touchpoint. Identify the specific GxP records that live outside the ERP today.
Weeks 3–4
Configure & Validate
Configure batch statuses, location classes, and Part 11 e-signature workflows. IQ/OQ documentation prepared. QA and compliance heads walk through with the vendor.
Weeks 5–8
Parallel Run
Live for one product family in parallel with existing paper/spreadsheet records. Discrepancies logged. Users trained on the mobile scan and e-signature workflow.
Weeks 9–12
Mock Audit
Internal team runs a 24-hour mock FDA inspection on the pilot product. Retrieval time, record completeness, and inspector-readiness measured against baseline.
Who Owns the KPI
A pharma WMS crosses stores, QA, quality compliance, and operations. Each function needs its own visible KPI, or the compliance discipline devolves into one person’s file cabinet.
Stores Head
First-scan put-away accuracy %
Owns the day-to-day discipline — every put-away, pick, and transfer scanned into the right zone the first time. Wrong-zone attempts logged, not just corrected.
QA Compliance
Audit-record retrieval time (target <4h)
Owns the inspection readiness — can a batch’s full history be produced inside the FDA 24-48h window, on demand, at any time?
Warehouse Supervisor
Excursion events / open CAPAs
Owns the environmental record and the excursion response — every excursion tied to a CAPA, and closure rate visible in the operations review.
Site Director
Form 483 observations at inspection
Owns the outcome — the number of warehouse-related observations at the next FDA or MHRA inspection. The KPI that everything above rolls up into.
FAQ
Doesn’t our ERP already do batch management — why do we need a separate WMS?
ERP batch management tracks the batch as a financial and material object — quantity, cost, purchase order, sales order. What it typically doesn’t track is the physical location inside the warehouse, the storage-condition enforcement at put-away, the continuous environmental record, or the 21 CFR Part 11 e-signature discipline at every movement. A pharma WMS layer sits between the physical warehouse and the ERP: it enforces the GxP rules at the scan, then writes the batch and movement records back to the ERP as system of record. The two work together — they are not either/or.
Book a demo to see the ERP write-back on one of your batches.
How does the 21 CFR Part 11 electronic signature actually work in practice?
Every action that would have required a wet signature under paper — goods-receipt confirmation, batch status change, quarantine release, movement approval — requires a unique user identifier plus a second authentication factor (password or biometric), captured at the moment of the action with a timestamp and a reason code. The record is tamper-evident: any change to it after the fact is itself logged. This meets 21 CFR Part 11 §11.100 for electronic signatures and §11.10 for closed-system controls. Your QA head and IT security lead walk through it together during the validation phase.
What about our existing SOPs — do we have to rewrite everything?
Some SOPs need updating; most do not. The workflow logic in the WMS is configured to match your existing SOPs, not the other way around. Where the SOP already reflects GMP best practice, the WMS enforces it at the scan. Where the SOP has drift or gaps, the pilot phase surfaces those and your QA team decides whether to update the SOP or reconfigure the workflow. Most facilities find 15–25% of their SOPs need light revision — usually to reflect the shift from paper signature to e-signature and from periodic reconciliation to continuous record.
Stop hoping the audit clock is on your side.
See a Live GMP Warehouse Workflow on Your Own Product
Bring one product family, one warehouse zone, and one recent audit finding. We’ll show the batch-control, storage-enforcement, and audit-trail workflow live — and quantify the retrieval-time gap against the FDA 24-48h expectation.
